Cost-effectiveness and cost-utility of hypertension and hyperlipidemia collaborative management between pharmacies and primary care in portugal alongside a trial compared with usual care (USFarmácia®)

Funding Information: The trial was promoted by the NHS Group of Primary Care Units [Agrupamento dos Centros de Saúde, or ACeS] of Baixo Mondego Region and the Portuguese National Association of Pharmacies [Associação Nacional das Farmácias, or ANF] and was funded by ANF. Study promoters and funders...

ver descrição completa

Detalhes bibliográficos
Autor principal: Costa, Suzete (author)
Outros Autores: Guerreiro, José (author), Teixeira, Inês (author), Helling, Dennis K. (author), Pereira, João (author), Mateus, Céu (author)
Formato: article
Idioma:eng
Publicado em: 2022
Assuntos:
community pharmacy
cost-effectiveness
cost-utility
economic
hyperlipidemia
hypertension
primary care
real-world
Pharmacology
Pharmacology (medical)
SDG 3 - Good Health and Well-being
Texto completo:http://hdl.handle.net/10362/144662
País:Portugal
Oai:oai:run.unl.pt:10362/144662

Texto Completo

http://hdl.handle.net/10362/144662

Registros relacionados